Literature DB >> 33239190

Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

J-P Machiels1, C René Leemans2, W Golusinski3, C Grau4, L Licitra5, V Gregoire6.   

Abstract

Entities:  

Keywords:  Clinical Practice Guidelines; SCCHN; diagnosis; follow-up; treatment

Mesh：

Year:  2020        PMID： 33239190     DOI： 10.1016/j.annonc.2020.07.011

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  72 in total

1.  Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivatives. The phase II, PANTERA/TTCC-2010-06 study.

Authors:  J Martínez-Trufero; A Lozano Borbalas; I Pajares Bernad; M Taberna Sanz; E Ortega Izquierdo; B Cirauqui Cirauqui; J Rubió-Casadevall; M Plana Serrahima; J M Ponce Ortega; I Planas Toledano; J Caballero; J Marruecos Querol; L Iglesias Docampo; J Lambea Sorrosal; J C Adansa; R Mesía Nin
Journal:  Clin Transl Oncol       Date:  2021-04-19       Impact factor: 3.405

2.  Factors associated with loss to follow-up after radiation therapy for head and neck cancer.

Authors:  John M Hoyle; Tanya A Correya; Kelly Kenzik; Liton Francisco; Sharon A Spencer; Christopher D Willey; James A Bonner; James W Snider; Drexell Hunter Boggs; William R Carroll; Smita Bhatia; Andrew M McDonald
Journal:  Head Neck       Date:  2022-01-25       Impact factor: 3.147

3.  LncRNA MALAT1 inhibits the proliferation and invasiveness of laryngeal squamous cell carcinoma Hep-2 cells by modulating miR-362-3p.

Authors:  Baotong Xie; Zhaohua Wang; Tao Li; Junfang Xue; Chunming Zhang
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

4.  Outcome of patients with recurrent/metastatic squamous cell head and neck cancer treated with platinum-based chemotherapy with or without cetuximab in real-world practice.

Authors:  Tina Zupančič; Branko Zakotnik; Cvetka Grašič Kuhar
Journal:  Mol Clin Oncol       Date:  2021-07-15

5.  [HPV-related oropharyngeal squamous cell carcinoma-Incidence steadily rising].

Authors:  M Suchan; N Wuerdemann; S J Sharma; J P Klussmann
Journal:  HNO       Date:  2021-06-18       Impact factor: 1.284

6.  Asymptomatic swallowing disorders may be present in individuals with laryngeal and hypopharyngeal cancer treated with chemo-radiotherapy.

Authors:  César Álvarez-Marcos; Andrea Vicente Benito; Agueda Gayol Fernández; Daniel Pedregal-Mallo; Paloma Sirgo Rodríguez; Liliana Santamarina Rabanal; José Luis Llorente; Fernando López; Juan Pablo Rodrigo
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-05-07       Impact factor: 2.503

Review 7.  Paradigm Change in First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.

Authors:  Edith Borcoman; Gregoire Marret; Christophe Le Tourneau
Journal:  Cancers (Basel)       Date:  2021-05-24       Impact factor: 6.639

Review 8.  Resection Margins in Head and Neck Cancer Surgery: An Update of Residual Disease and Field Cancerization.

Authors:  Annouk S Pierik; C René Leemans; Ruud H Brakenhoff
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

Review 9.  Relevance of Human Papillomaviruses in Head and Neck Cancer-What Remains in 2021 from a Clinician's Point of View?

Authors:  Markus Hoffmann; Elgar Susanne Quabius
Journal:  Viruses       Date:  2021-06-18       Impact factor: 5.048

10.  Patient-Reported Outcomes Assessing the Impact of Palliative Radiotherapy on Quality of Life and Symptom Burden in Head and Neck Cancer Patients: A Systematic Review.

Authors:  Alexander Fabian; Justus Domschikowski; Markus Hoffmann; Oliver Weiner; Claudia Schmalz; Jürgen Dunst; David Krug
Journal:  Front Oncol       Date:  2021-06-04       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.